SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001600620-24-000064
Filing Date
2024-05-03
Accepted
2024-05-03 16:08:45
Documents
23
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A auph-20240502.htm   iXBRL DEF 14A 1472198
3 auph-20240502_g1.jpg GRAPHIC 11010
4 auph-20240502_g10.jpg GRAPHIC 184479
5 auph-20240502_g11.jpg GRAPHIC 153641
6 auph-20240502_g12.jpg GRAPHIC 38273
7 auph-20240502_g2.jpg GRAPHIC 49796
8 auph-20240502_g3.jpg GRAPHIC 83530
9 auph-20240502_g4.jpg GRAPHIC 15830
10 auph-20240502_g5.jpg GRAPHIC 13320
11 auph-20240502_g6.jpg GRAPHIC 125343
12 auph-20240502_g7.jpg GRAPHIC 111152
13 auph-20240502_g8.jpg GRAPHIC 109843
14 auph-20240502_g9.jpg GRAPHIC 114508
  Complete submission text file 0001600620-24-000064.txt   4652302

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20240502.xsd EX-101.SCH 934
26 EXTRACTED XBRL INSTANCE DOCUMENT auph-20240502_htm.xml XML 118698
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36421 | Film No.: 24913108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)